JP7454281B2 - Highly functional protein porridge premix containing peas, rice mixture, and rice bran and method for producing the same - Google Patents
Highly functional protein porridge premix containing peas, rice mixture, and rice bran and method for producing the same Download PDFInfo
- Publication number
- JP7454281B2 JP7454281B2 JP2022141906A JP2022141906A JP7454281B2 JP 7454281 B2 JP7454281 B2 JP 7454281B2 JP 2022141906 A JP2022141906 A JP 2022141906A JP 2022141906 A JP2022141906 A JP 2022141906A JP 7454281 B2 JP7454281 B2 JP 7454281B2
- Authority
- JP
- Japan
- Prior art keywords
- porridge
- rice
- peas
- premix
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000010582 Pisum sativum Nutrition 0.000 title claims description 97
- 235000007164 Oryza sativa Nutrition 0.000 title claims description 88
- 235000009566 rice Nutrition 0.000 title claims description 88
- 240000004713 Pisum sativum Species 0.000 title claims description 67
- 235000021395 porridge Nutrition 0.000 title claims description 66
- 239000000203 mixture Substances 0.000 title claims description 38
- 102000004169 proteins and genes Human genes 0.000 title claims description 31
- 108090000623 proteins and genes Proteins 0.000 title claims description 31
- 238000004519 manufacturing process Methods 0.000 title claims description 19
- 240000007594 Oryza sativa Species 0.000 title 2
- 241000209094 Oryza Species 0.000 claims description 86
- 239000000843 powder Substances 0.000 claims description 40
- 241000219843 Pisum Species 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 229940024606 amino acid Drugs 0.000 claims description 22
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 22
- 239000011707 mineral Substances 0.000 claims description 22
- 150000001413 amino acids Chemical class 0.000 claims description 21
- 229940088594 vitamin Drugs 0.000 claims description 19
- 229930003231 vitamin Natural products 0.000 claims description 19
- 235000013343 vitamin Nutrition 0.000 claims description 19
- 239000011782 vitamin Substances 0.000 claims description 19
- 206010033546 Pallor Diseases 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 10
- 108091005804 Peptidases Proteins 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 102000035195 Peptidases Human genes 0.000 claims description 8
- 235000019155 vitamin A Nutrition 0.000 claims description 7
- 239000011719 vitamin A Substances 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000011777 magnesium Substances 0.000 claims description 6
- 229910052749 magnesium Inorganic materials 0.000 claims description 6
- 229960002477 riboflavin Drugs 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 5
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 5
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 238000000354 decomposition reaction Methods 0.000 claims description 5
- 230000002255 enzymatic effect Effects 0.000 claims description 5
- 229960000310 isoleucine Drugs 0.000 claims description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 239000004474 valine Substances 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 238000006911 enzymatic reaction Methods 0.000 claims description 4
- 235000019192 riboflavin Nutrition 0.000 claims description 4
- 239000002151 riboflavin Substances 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 3
- 239000011720 vitamin B Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 229930003270 Vitamin B Natural products 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 25
- 235000010755 mineral Nutrition 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 18
- 230000036039 immunity Effects 0.000 description 18
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 15
- 235000013305 food Nutrition 0.000 description 15
- 235000016709 nutrition Nutrition 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 11
- 235000010469 Glycine max Nutrition 0.000 description 10
- 244000068988 Glycine max Species 0.000 description 10
- 244000046052 Phaseolus vulgaris Species 0.000 description 9
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 9
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 9
- 235000012054 meals Nutrition 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 108010074328 Interferon-gamma Proteins 0.000 description 8
- 102000004889 Interleukin-6 Human genes 0.000 description 8
- 108090001005 Interleukin-6 Proteins 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 8
- 102000013462 Interleukin-12 Human genes 0.000 description 7
- 108010065805 Interleukin-12 Proteins 0.000 description 7
- 102000000588 Interleukin-2 Human genes 0.000 description 7
- 108010002350 Interleukin-2 Proteins 0.000 description 7
- 108010084695 Pea Proteins Proteins 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 235000012041 food component Nutrition 0.000 description 7
- 230000015788 innate immune response Effects 0.000 description 7
- 235000019702 pea protein Nutrition 0.000 description 7
- 235000013311 vegetables Nutrition 0.000 description 7
- 102000004127 Cytokines Human genes 0.000 description 6
- 108090000695 Cytokines Proteins 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 239000012228 culture supernatant Substances 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 229940100601 interleukin-6 Drugs 0.000 description 6
- 210000000265 leukocyte Anatomy 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 238000008157 ELISA kit Methods 0.000 description 5
- 102100037850 Interferon gamma Human genes 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000005778 DNA damage Effects 0.000 description 4
- 231100000277 DNA damage Toxicity 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 238000004820 blood count Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000019750 Crude protein Nutrition 0.000 description 3
- 102000008070 Interferon-gamma Human genes 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000001055 chewing effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 108010007119 flavourzyme Proteins 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000002865 immune cell Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229960003130 interferon gamma Drugs 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 108010004032 Bromelains Proteins 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 2
- 244000043158 Lens esculenta Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- -1 Protamex Proteins 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003840 blood vessel health Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000003927 comet assay Methods 0.000 description 2
- 231100000170 comet assay Toxicity 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 235000020721 horse chestnut extract Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 230000018984 mastication Effects 0.000 description 2
- 238000010077 mastication Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 235000017807 phytochemicals Nutrition 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 235000013324 preserved food Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 101100508420 Mus musculus Ifng gene Proteins 0.000 description 1
- 101001076414 Mus musculus Interleukin-6 Proteins 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N Nitrogen oxide(NO) Natural products O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 229940117681 interleukin-12 Drugs 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000021332 kidney beans Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- ACCDBHBOYZJSDT-UHFFFAOYSA-N n-(4-bromophenyl)-2-fluoroacetamide Chemical compound FCC(=O)NC1=CC=C(Br)C=C1 ACCDBHBOYZJSDT-UHFFFAOYSA-N 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108060006613 prolamin Proteins 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 208000001076 sarcopenia Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/101—Addition of antibiotics, vitamins, amino-acids, or minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
- A23L23/10—Soup concentrates, e.g. powders or cakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0626—Isoleucine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0628—Leucine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0654—Valine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1578—Calcium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/161—Magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1642—Zinc
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/702—Vitamin A
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Description
本発明は、エンドウと米混合物と米糠とを含有する高タンパク質機能性粥プレミックスの製造方法に関する。より詳細には、完全米、米グリッツ及び米粉末からなる米混合物60~99w%、及び安定化した米糠粉末1~40w%から構成された粥プレミックスにおいて、タンパク質源としてのエンドウ粉末10~50w%、分枝アミノ酸1~10%、ビタミンA70~80μgRAE/100g、ビタミンB2(リボフラビン)0.14~0.16mg/100g、ビタミンC8~12mg/100g、カルシウム70~90mg/100g、亜鉛8~12mg/100g、マグネシウム50~70mg/100gを含むタンパク質高機能性粥プレミックス及びその製造方法に関する。 The present invention relates to a method for producing a high protein functional porridge premix containing peas, rice mixture and rice bran. More specifically, in a porridge premix consisting of 60-99 w% of a rice mixture consisting of whole rice, rice grits and rice flour, and 1-40 w% of stabilized rice bran powder, 10-50 w of pea powder as a protein source. %, branched amino acids 1-10%, vitamin A 70-80μg RAE/100g, vitamin B2 (riboflavin) 0.14-0.16mg/100g, vitamin C 8-12mg/100g, calcium 70-90mg/100g, zinc 8-12mg The present invention relates to a protein-rich porridge premix containing 50 to 70 mg/100 g of magnesium and a method for producing the same.
粥(rice porridge)は、穀物や澱粉を含有した食材料を粉砕して水と一緒に煮て粒が脆くなるように作ったものであって、消化しやすいという特徴がある。よって、患者又は幼児に提供する食事でもあるが、正常人も、アワビ粥、鶏粥、野菜粥、小豆粥などを保養食又は嗜好食として食べることもある。韓国の場合、医療技術が発達し且つ国民健康保険のサービスが広がることにより、平均寿命が増えて高齢者人口が急増しながら、超高齢化社会に入っている。ほとんどの高齢患者は、老人病院や老人療養院、昼夜間保護施設に頼って、国民健康保険公団の長期療養支援金を受け取っている。このような老人専門療養施設は、全国的に5,000個余りを超えており、急速に増加しつつある。
入院した高齢患者のうち、1日3食を粥で解決する高齢患者は、約30%に迫っている。粥を作る従来の方法は、米を水に浸漬してから煮込むのに時間がかかり、調理する者が必要であって老人療養施設入居者に大量の粥を提供することが難しく、高齢患者の食事代用として栄養成分が不足し、喉越しが不便であるという問題点がある。別の方法としては、米を微粉砕した後、煮込んで粥を製造する方法もあるが、この場合には、重湯のように粥が作られ、飲食者が咀嚼活動をほとんど行わないので咀嚼感が低下して、食事代用食品としての活用度に劣るという問題点がある。
したがって、粥を短時間で作ることができ、柔らかい食感と咀嚼感を同時に感じながら、栄養的な満足と免疫力のある高齢患者の食事代用食や幼児の離乳食として機能性粥が切実に必要な実情である。
Rice porridge is made by crushing food materials containing grains and starch and boiling them with water to make the grains brittle, making them easy to digest. Therefore, although it is a meal provided to patients or infants, normal people may also eat abalone porridge, chicken porridge, vegetable porridge, red bean porridge, etc. as a health or leisure food. In the case of South Korea, with the development of medical technology and the expansion of national health insurance services, the average life expectancy has increased and the elderly population has rapidly increased, making it a super-aging society. Most elderly patients rely on geriatric hospitals, nursing homes, and day and night shelters to receive long-term care support funds from the National Health Insurance Corporation. There are more than 5,000 such geriatric care facilities nationwide, and the number is rapidly increasing.
Approximately 30% of hospitalized elderly patients eat porridge for three meals a day. The traditional method of making porridge takes time to soak rice in water and then boil it, requires a cook, and makes it difficult to provide large quantities of porridge to elderly patients. As a meal substitute, it lacks nutritional components and is inconvenient to swallow. Another method is to pulverize the rice and then boil it to produce porridge, but in this case, the porridge is made like a heavy soup, and the eater hardly engages in mastication, so the chewing sensation is poor. There is a problem in that it has a lower value, making it less useful as a meal replacement food.
Therefore, there is an urgent need for a functional porridge that can be prepared in a short time, has a soft texture and a chewy texture at the same time, and can be used as a meal replacement food for elderly patients with nutritional satisfaction and strong immunity, or as a baby food for infants. This is the actual situation.
動植物は、2種類の免疫システムを持っている。すなわち、先天性免疫(innate
immunity)は、非特異的免疫(自然免疫、内在免疫)方法で宿主が感染しないように防御する細胞や免疫メカニズムである。特定の病原体、抗原を記憶せずに即座に反応する免疫システムを持っている。マクロファージなどの食細胞や体内の抗生物質などが体内免疫において重要な役割を果たすが、先天性免疫細胞から分泌される代表的なサイトカインは、インターロイキン6(IL-6)、インターロイキン12(IL-12)、腫瘍壊死因子-α(tumor necrosis factoralpha;TNF-α)である。
一方、後天性免疫(acquired immunity)は、特異的免疫(適応免疫、獲得免疫)は、抗原に暴露された後に誘導されるが、将来同じ抗原に暴露すると、記憶された免疫作用が誘導される。高等生命体で病原体に曝露された個体の感染初期に後天免疫が働かない期間には、先天免疫が優先的に働き、続いてより効率的な後天免疫が働く。後天免疫過程は、B細胞やT細胞などが主導的な役割を果たすが、後天性免疫細胞から分泌される代表的なサイトカインは、インターロイキン2(IL-2)とインターフェロンガンマ(interferon-gamma、IFN-γ)である。
Animals and plants have two types of immune systems. In other words, innate immunity
immunity) refers to cells and immune mechanisms that protect the host from infection using non-specific immunity (natural immunity, intrinsic immunity). It has an immune system that responds immediately to specific pathogens and antigens without remembering them. Phagocytic cells such as macrophages and antibiotics in the body play important roles in the body's immunity, but the typical cytokines secreted by innate immune cells are interleukin-6 (IL-6) and interleukin-12 (IL-6). -12) and tumor necrosis factor-α (TNF-α).
On the other hand, acquired immunity refers to specific immunity (adaptive immunity, acquired immunity) that is induced after exposure to an antigen, but when exposed to the same antigen in the future, a memorized immune effect is induced. . During the early stages of infection in individuals exposed to pathogens in higher organisms, when acquired immunity is not active, innate immunity acts preferentially, followed by more efficient acquired immunity. In the acquired immune process, B cells and T cells play a leading role, and the typical cytokines secreted from acquired immune cells are interleukin 2 (IL-2) and interferon-gamma (interferon-gamma). IFN-γ).
エンドウ(peas)は、双子葉植物であって、マメ科の一・二年草である。エンドウは、小豆やインゲンマメのようにかてとして、餅・お菓子にまぶすマメなどの粉として用いられているだけでなく、未熟の種子であるグリーンピースの場合には缶詰として、幼い莢の場合には野菜として、葉・茎の場合には家畜の飼料として用いられており、タンパク質、複合炭水化物、繊維質、無機質、ビタミン及び抗酸化物質を含有して優秀な栄養供給源として用いられている。
エンドウの一般成分は、水分8.1g、タンパク質20.7g、炭水化物65.1g、脂質1.3g、灰分2.8gである。エンドウ(100gに食物繊維6gを含有)の食物繊維は、老廃物の排出と腸の健康に役立ち、オメガ3脂肪酸が含有されているため脳細胞活動を促進し、脂肪酸としてリノレン酸とオレイン酸が含有されてコレステロール数値を下げ、カリウムやナトリウムの排出を助けて血管の健康に役立ち、イソフラボン成分が抗酸化剤の役目をして有害酸素を取り除き、サポニンとビタミンKが含有されてがん細胞の成長抑制に役立つ。エンドウは、粗タンパク質14~31%、アルブミン15~25%、グロブリン49~70%、グルテリン11%、プロラミン5%、リジン8.9%、グルタミン11%、シスチン、アルギニンなどが含有されており、ミネラル、ビタミンB1が含有されて筋肉の損失を防ぎ、タンパク質合成を助けるアミノ酸が豊富であって筋肉の増加に役立つ。エンドウは、腸健康、脳健康、血管健康、筋肉増加、がん予防などに良いと言われている。
Peas are dicotyledonous plants, and are annual or biennial plants of the Fabaceae family. Peas are not only used as a filler like azuki beans and kidney beans, and as flour for sprinkled on rice cakes and sweets, but also as green peas, which are immature seeds, canned food, and in the case of young pods, they are used as canned food. It is used as a vegetable, and the leaves and stems are used as feed for livestock.It is an excellent source of nutrients, containing protein, complex carbohydrates, fiber, minerals, vitamins and antioxidants. .
The general components of peas are 8.1 g of water, 20.7 g of protein, 65.1 g of carbohydrates, 1.3 g of fat, and 2.8 g of ash. The dietary fiber in peas (100g contains 6g of dietary fiber) helps eliminate waste and promotes intestinal health.The content of omega-3 fatty acids promotes brain cell activity, and the fatty acids linolenic acid and oleic acid Contains lower cholesterol levels, aids in the excretion of potassium and sodium, and is useful for blood vessel health. Isoflavone components act as antioxidants and remove harmful oxygen, and saponins and vitamin K contain saponins and vitamin K, which help fight cancer cells. Helps suppress growth. Peas contain 14-31% crude protein, 15-25% albumin, 49-70% globulin, 11% glutelin, 5% prolamin, 8.9% lysine, 11% glutamine, cystine, arginine, etc. It contains minerals and vitamin B1 to prevent muscle loss, and is rich in amino acids that aid in protein synthesis, helping to increase muscle mass. Peas are said to be good for intestinal health, brain health, blood vessel health, muscle growth, and cancer prevention.
大豆(soy bean)は、タンパク質35~47%、炭水化物30%、脂肪15~20%で構成されており、食物繊維、リン、鉄、カルシウム、ビタミンB1に富む栄養食品である。大豆は、アミノ酸の種類も様々であって、生命維持に重要な必須アミノ酸、例えばグリシンやアルギニンなどの含有量が高く、質の高いタンパク質を供給する。胃と腸でグルコースの吸収速度を下げて糖尿病を抑制し、植物性エストロゲンであるイソフラボンが豊富に含まれており、骨粗鬆症の予防にも良い。ビタミンEが豊富であって血液循環を円滑にすることにより老化を防ぎ、腸内の腸運動を促進させるビフィズス菌を活性化して便秘の治療にも効果がある。ゲニステイン、サポニン、フィット酸、ファイトステロールなど、大豆に含有されている機能成分は、乳がん、直腸がん、結腸がん、肺がん、胃がん、前立腺がんの減少に役立つといわれる。大豆のレシチンは、脳の集中力を向上させ、認知症や物忘れを改善し、脳の老化を防ぐという効果がある。大豆のイソフラボンは、体内のコレステロールを減らし、女性ホルモンであるエストロゲンが過剰に分泌されるのを抑制する作用をして、乳がんや卵巣がん等を予防するうえ、更年期症状を緩和する。成人病や脱毛の予防だけでなく、ダイエットにも効果的であり、黒い殻に含有されているアントシアニン色素は、有害な活性酸素を取り除く強力な抗酸化成分があり、抗がん及び老化予防に役立つ。特に、黒豆は、世界10大フードに選ばれており、パワーフードとも呼ばれる。 Soy beans are a nutritional food that is composed of 35-47% protein, 30% carbohydrates, and 15-20% fat, and is rich in dietary fiber, phosphorus, iron, calcium, and vitamin B1. Soybeans contain various types of amino acids, have a high content of essential amino acids important for life support, such as glycine and arginine, and supply high-quality protein. It suppresses diabetes by slowing the absorption of glucose in the stomach and intestines, and is rich in isoflavones, which are phytoestrogens, and is good for preventing osteoporosis. Rich in vitamin E, it prevents aging by smoothing blood circulation, and is effective in treating constipation by activating bifidobacteria, which promote intestinal motility. The functional components contained in soybeans, such as genistein, saponin, phytate, and phytosterol, are said to help reduce breast cancer, rectal cancer, colon cancer, lung cancer, stomach cancer, and prostate cancer. Soybean lecithin has the effect of improving brain concentration, improving dementia and forgetfulness, and preventing brain aging. Isoflavones in soybeans reduce cholesterol in the body and suppress the excessive secretion of the female hormone estrogen, preventing breast cancer, ovarian cancer, etc., and alleviating menopausal symptoms. It is effective not only for preventing adult diseases and hair loss, but also for dieting.The anthocyanin pigment contained in the black shell has a strong antioxidant component that removes harmful active oxygen, and has anti-cancer and anti-aging effects. Helpful. In particular, black beans have been selected as one of the top 10 foods in the world and are also called power foods.
分枝アミノ酸(Branched Chain Amino Acid;BCAA)は、バリン(valine)、ロイシン(Leucine)、イソロイシン(Isoleucine)などの側鎖に分枝アルカリがあるアミノ酸であって、疎水性アミノ酸でもある。酵素などである活性中心のポケットにおける結合部位の形成に寄与している。ロイシンはαらせん構造の形成を促進し、バリン、イソロイシンはβ構造に存在することが多い。これらは、ヒトにとっては、栄養面では必須アミノ酸に属する。BCAAの3種は、肝臓を経ずに筋肉に直ちに移行して代謝し、筋肉に必要なエネルギーを与えて筋肉の生成を助け、筋肉細胞の活性を助ける。特に高齢患者や手術患者は、摂取したタンパク質がアミノ酸に分解される割合が低く、筋肉タンパク質に再建される割合が低い。特に、分枝アミノ酸中のロイシンは、筋肉減少症治療の補助剤として使われる。 Branched Chain Amino Acid (BCAA) is an amino acid having a branched alkali in its side chain, such as valine, leucine, and isoleucine, and is also a hydrophobic amino acid. It contributes to the formation of binding sites in the pockets of active centers such as enzymes. Leucine promotes the formation of an α-helical structure, while valine and isoleucine often exist in a β-helical structure. These belong to the nutritionally essential amino acids for humans. The three types of BCAAs are immediately transferred to the muscles without passing through the liver and are metabolized, providing the muscles with the energy they need, helping to generate muscles, and aiding the activation of muscle cells. In particular, elderly patients and surgical patients have a low rate of ingested protein being broken down into amino acids and a low rate of being rebuilt into muscle protein. In particular, leucine, a branched amino acid, is used as an adjunct in the treatment of sarcopenia.
エンドウに関連する従来技術としては、韓国特許第10-2028652号(エンドウ粉末、発酵米糠、米の胚芽、トウキ抽出粉末、高麗人参抽出粉末、蜂蜜粉末及びココア粉
末を含む粉末状の総合栄養補助食品)は、エンドウ粉末、発酵米糠、米の胚芽、トウキ抽出粉末、高麗人参抽出粉末、蜂蜜粉末及びココア粉末を含む粉末状の総合栄養補助食品に関する。
韓国特許公開第10-2021-0008845号(加水分解されたエンドウタンパク質ベースの栄養組成物)では、エンドウタンパク質加水分解物を含む少なくとも1つのタンパク質源は、全体組成物の2.25wt%~6.5wt%を構成し、1つ以上の植物化学抽出物、1つ以上の脂肪酸、1つ以上のオーガニック成分、1つ以上のプレバイオティック繊維を含む栄養組成物である。
韓国特許公開第10-2021-0020080号(完全なエンドウタンパク質ベースの栄養組成物)は、腸内投与、経口投与用の完全なエンドウタンパク質ベースの栄養組成物であって、オーガニック及び植物ベースの成分で作られる。前記栄養組成物は、エンドウタンパク質、植物化学抽出物、脂肪酸、上位8個のアレルゲンがないオーガニック成分、及びプレバイオティック繊維を含む。前記栄養組成物は、腸内投与及び経口投与のために液体として提供される。しかし、これらの従来技術は、本発明とは技術的構成が異なるものである。
As for the prior art related to peas, Korean Patent No. 10-2028652 (Powdered comprehensive nutritional supplement containing pea powder, fermented rice bran, rice germ, horse chestnut extract powder, ginseng extract powder, honey powder, and cocoa powder) ) relates to a powdered comprehensive nutritional supplement containing pea powder, fermented rice bran, rice germ, horse chestnut extract powder, ginseng extract powder, honey powder and cocoa powder.
In Korean Patent Publication No. 10-2021-0008845 (Hydrolyzed Pea Protein Based Nutritional Composition), at least one protein source comprising pea protein hydrolyzate is present in an amount of 2.25 wt% to 6.5 wt% of the total composition. 5 wt% and includes one or more phytochemical extracts, one or more fatty acids, one or more organic ingredients, one or more prebiotic fibers.
Korean Patent Publication No. 10-2021-0020080 (Complete Pea Protein-Based Nutritional Composition) is a complete pea protein-based nutritional composition for enteral and oral administration, comprising organic and plant-based ingredients. Made with. The nutritional composition includes pea protein, phytochemical extracts, fatty acids, organic ingredients free of top 8 allergens, and prebiotic fiber. The nutritional composition is provided as a liquid for enteral and oral administration. However, these conventional techniques have different technical configurations from the present invention.
本発明者らは、米混合物及び安定化した米糠を含有する機能性粥プレミックス及びその製造方法に関する韓国特許第10-1441565号を開示したことがある。完全米、米グリッツ(grits)及び米粉末からなる米混合物60~99w%、及び安定化した米糠粉末1~40w%を含む粥プレミックスに関する。
しかし、米混合物に含有されたタンパク質は、7~8g/100g程度であって、1食の粥ではタンパク質含有量が低いため、食事代用では不完全であるという点があった。
したがって、本発明は、前記粥プレミックスに足りないタンパク質を補強するために研究を重ねた結果、粗タンパク質の含有量が高い豆類のうち、物性と味の良いエンドウを添加し、その他に分枝アミノ酸、ビタミン及びミネラルを添加して機能性粥プレミックスを製造する方法を完成した。
The present inventors have previously disclosed Korean Patent No. 10-1441565 regarding a functional porridge premix containing a rice mixture and stabilized rice bran and a method for producing the same. A porridge premix comprising 60-99 w% of a rice mixture consisting of whole rice, rice grits and rice flour, and 1-40 w% of stabilized rice bran powder.
However, the protein contained in the rice mixture was about 7 to 8 g/100 g, and the protein content in one meal of porridge was low, so it was insufficient as a meal substitute.
Therefore, as a result of repeated research in order to supplement the protein lacking in the porridge premix, the present invention added peas, which have good physical properties and taste, among legumes with a high crude protein content, and added branched peas to other beans. A method for producing a functional porridge premix by adding amino acids, vitamins and minerals was completed.
本発明者が開示した韓国特許第10-1441565号(米混合物及び安定化した米糠を含有する機能性粥プレミックス及びその製造方法)は、(S1)米を粉砕して、3つの粒度サイズを有する完全米、米グリッツ及び米粉末に分けて準備するステップと、(S2)前記完全米、米グリッツ及び米粉末を2.5~3.5:4.5~5.5:1.5~2.5の重量比で混合するステップと、(S3)前記混合された米混合物60~99重量%及び安定化した米糠粉末1~40w%を混合して粥プレミックスを得るステップとから構成されている。
本発明者は、上記に開示した韓国特許第10-1441565号の「米混合物及び安定化した米糠を含有する機能性粥プレミックス」の欠点である足りないタンパク質を補うために、動物性タンパク質中の卵タンパク質、乳清タンパク質又は植物性タンパク質中の豆(大豆)、エンドウ及びレンズ豆の中からエンドウを選択した。
エンドウは、餡、又は餅・お菓子にまぶすマメなどの粉として広く用いられて消費者に馴染むだけでなく、栄養性、物性及び味が良く、米混合物との親和力が良い素材である。特に、高齢患者は、消化力に劣り、食べ物を噛む咀嚼感が不足し、喉越しが悪いという点を考慮した。大豆は、脂肪質含有量が高いという利点があるが、プレミックスの素材として使用するには大豆の脂肪を除去しなければならず、脱脂大豆は、組織が硬くて咀嚼性と喉越しが悪いため、大豆よりは柔らかくて味の良いエンドウをプレミックス素材として選択した。
エンドウをブランチング(branching)及び急速冷却させて酵素作用が抑制されることにより、栄養成分の損失を防止し且つ風味を維持させることができる。また、ブランチング及び急速冷却したエンドウを粉砕し、酵素分解して高齢患者に吸収されやすくする。
本発明は、エンドウを精製水で洗浄、浸漬した後、水気を除去して高温で殺菌及びブランチングしたエンドウを低温で急速冷却したエンドウを粉砕するステップと、エンドウ粉末に10倍の精製水を加えて均質化させた後、公知の商業用タンパク分解酵素を用いて加水分解させるステップと、前記加水分解物を熱処理して酵素反応を停止させた後、遠心分離してエンドウ酵素分解物を得るステップと、前記酵素分解物を乾燥させた後、篩別し、異物を除去するステップと、エンドウ粉末、米混合物(完全米、米グリッツ、米粉末)、米糠粉末、分枝アミノ酸、及び微量のビタミンとミネラルを混合して粥プレミックスを作るステップと、を含んでなるタンパク質高機能性粥プレミックスの製造方法である。
Korean Patent No. 10-1441565 (Functional Porridge Premix Containing Rice Mixture and Stabilized Rice Bran and Method for Producing the Same) disclosed by the present inventor discloses (S1) grinding rice into three particle sizes. (S2) separating and preparing the whole rice, rice grits and rice powder having a ratio of 2.5 to 3.5:4.5 to 5.5:1.5; (S3) mixing 60 to 99 wt % of the mixed rice mixture and 1 to 40 w % of the stabilized rice bran powder to obtain a porridge premix. ing.
In order to compensate for the lack of protein, which is a drawback of the "Functional Porridge Premix Containing Rice Mixture and Stabilized Rice Bran" of Korean Patent No. 10-1441565 disclosed above, the present inventor added animal protein to Peas were selected from beans (soybeans), peas and lentils in egg protein, whey protein or vegetable protein.
Peas are widely used as bean paste or bean powder to sprinkle on rice cakes and sweets, and are not only popular with consumers, but also have good nutrition, physical properties, and taste, and are a material that has good affinity with rice mixtures. In particular, we took into consideration the fact that elderly patients have poor digestive power, lack the sense of chewing food, and have difficulty passing food down their throats. Soybeans have the advantage of having a high fat content, but the fat must be removed from soybeans before they can be used as a premix material, and defatted soybeans have a hard tissue that makes them difficult to chew and pass down the throat. Therefore, peas, which are softer and have a better taste than soybeans, were selected as the premix material.
By blanching and rapidly cooling the peas to suppress enzyme action, loss of nutritional components can be prevented and flavor can be maintained. Additionally, blanched and rapidly cooled peas are crushed and enzymatically degraded to make them more easily absorbed by elderly patients.
The present invention involves the steps of washing and soaking peas in purified water, removing moisture, sterilizing and blanching the peas at a high temperature, rapidly cooling the peas at a low temperature, and then grinding the peas, and adding 10 times as much purified water to the pea powder. In addition, after homogenization, a step of hydrolyzing using a known commercial proteolytic enzyme, and heat treatment of the hydrolyzate to stop the enzymatic reaction, followed by centrifugation to obtain a pea enzymatically decomposed product. a step of drying the enzymatic decomposition product and then sieving it to remove foreign substances; a step of drying the enzymatically decomposed product and removing foreign substances; A method for producing a protein-rich porridge premix, comprising: mixing vitamins and minerals to make a porridge premix.
前記植物性原料の中でもタンパク質含有量の高い豆(大豆)、レンズ豆及び蚕豆の中から選択された少なくとも1つに対して脱脂、粉砕などの前処理を経た後、エンドウの一部を代替してエンドウと一緒に併用することができる。また、分離大豆タンパク質や植物性タンパク質をエンドウと併用することができる。 Among the vegetable raw materials, at least one selected from beans (soybeans), lentils, and silkworm beans, which have a high protein content, is subjected to pretreatment such as defatting and pulverization, and then a part of the peas is substituted. Can be used together with peas. Also, isolated soybean protein or vegetable protein can be used in combination with peas.
本発明の粥プレミックスは、米混合物、米糠、エンドウタンパク質、分枝アミノ酸、ビ
タミン及びミネラルが補強された高機能性タンパク質粥を提供することができる。特に、エンドウを殺菌及びブランチングした後、急冷させて酵素作用を抑制することにより、栄養成分の損失防止及び風味維持に役立てることができる。また、タンパク分解酵素で加水分解させてタンパク質含有量を高めることにより、免疫力と体重が維持されながら、高齢患者に滑らかな喉越しと咀嚼感で吸収が容易であって高齢患者の回復が速い。本発明は、高齢者の保養食、大人の食事代用食、乳幼児の栄養食として用いられることができる。
The porridge premix of the present invention can provide a highly functional protein porridge enriched with rice mixture, rice bran, pea protein, branched amino acids, vitamins and minerals. In particular, after sterilizing and blanching peas, quenching them to suppress enzyme action can be useful for preventing loss of nutritional components and maintaining flavor. In addition, by increasing the protein content through hydrolysis with proteolytic enzymes, it maintains immunity and body weight, while providing smooth swallowing and chewing sensation for elderly patients, making it easy to absorb and allowing elderly patients to recover quickly. . The present invention can be used as a health food for the elderly, a meal replacement food for adults, and a nutritional food for infants.
本発明のエンドウのブランチング技術を導入した機能性タンパク質粥プレミックス製造工程は、次の通りである。
エンドウを精製水で洗浄して浸漬した後、エンドウの水気を除去するステップと、エンドウを高温で殺菌しながらブランチしたエンドウを低温で急速に冷却したエンドウを粉砕するステップと、エンドウ粉末に精製水を加えて均質化させた後、商業用タンパク質分解酵素を添加して振盪恒温水槽で加水分解させ、前記加水分解物を高温で熱処理して酵素を失活させた後、遠心分離してエンドウ酵素分解物を得るステップと、前記エンドウ酵素分解物を乾燥させた後、適当なサイズに篩別して異物を除去するステップと、エンドウ粉末、米混合物(完全米、米グリッツ、米粉末)、米糠粉末、分枝アミノ酸、ビタミン及びミネラルを混合して粥プレミックスを作るステップと、を含んでなる。
上記エンドウのブランチングは、豆や野菜類の酵素作用を抑制して栄養成分の損失を防止し、風味を維持させることができる。また、上記でエンドウをブランチングし、急速に冷却した後、破砕して酵素分解させると、エンドウの組織感を向上させることにより、物性と味が良くなり、高齢患者への吸収が容易である。また、酵素処理エンドウは、栄養性に優れるのに対し、炊飯後の硬度が高い方であって、咀嚼及び消化性が改善される。
The process for producing a functional protein porridge premix incorporating the pea blanching technology of the present invention is as follows.
After washing and soaking the peas in purified water, there is a step of removing moisture from the peas, a step of sterilizing the peas at a high temperature while rapidly cooling the blanched peas at a low temperature, and then grinding the peas, and adding purified water to the pea powder. After homogenization, a commercial protease was added and hydrolyzed in a shaking constant temperature water bath. The hydrolyzate was heat-treated at high temperature to inactivate the enzyme, and then centrifuged to dissolve the pea enzyme. a step of obtaining a decomposed product; a step of drying the enzymatically decomposed pea product and then sieving it to an appropriate size to remove foreign substances; a step of pea powder, rice mixture (complete rice, rice grits, rice powder), rice bran powder, mixing branched amino acids, vitamins and minerals to form a porridge premix.
Blanching the peas can suppress the enzyme action of beans and vegetables, prevent loss of nutritional components, and maintain flavor. In addition, blanching the peas as described above, cooling them rapidly, and then crushing and enzymatically decomposing them improves the texture of the peas, resulting in better physical properties and taste, making it easier for elderly patients to absorb. . In addition, while enzyme-treated peas have excellent nutritional properties, they have a higher hardness after cooking, which improves chewability and digestibility.
1)エンドウの洗浄、浸漬、脱水
市中で購入(ガラク市場)したエンドウを流水又は精製水で綺麗に洗浄する。洗浄したエンドウを18~25℃の精製水に3~4時間浸漬して十分にふやかした後、エンドウの水気を笊で4~5時間除去する。
1) Washing, soaking, and dehydrating peas Wash peas purchased in the market (Garak market) thoroughly with running water or purified water. The washed peas are soaked in purified water at 18 to 25°C for 3 to 4 hours to sufficiently soak them, and then the water from the peas is removed using a strainer for 4 to 5 hours.
2)エンドウのブランチング、急速冷却及び粉砕
エンドウを78~82℃で20~30分間ブランチングしながら殺菌したエンドウを0~5℃で1~2時間急速冷却する。上記の急速冷却したエンドウを90~100メッシュに粉砕する。上記におけるエンドウのブランチングは、豆や野菜類の酵素作用を抑制して
栄養成分の損失を防止し、風味を維持させることができる。また、ブランチングした後、急速冷却したエンドウは、柔らかい組織感を与えることができる。
2) Blanching, rapid cooling and crushing of peas While blanching the peas at 78-82°C for 20-30 minutes, the sterilized peas are rapidly cooled at 0-5°C for 1-2 hours. Grind the rapidly cooled peas to 90-100 mesh. Blanching the peas described above can suppress the enzyme action of beans and vegetables, prevent loss of nutritional components, and maintain flavor. In addition, peas that are rapidly cooled after blanching can give a soft texture.
3)エンドウ粉末の酵素分解
水とエンドウ粉末を9~10:1に均質化させた後、商業用タンパク分解酵素0.1~1.0%(w/v)を添加してpH4~5、40~50℃にて10~30分間振盪恒温水槽で加水分解させる。
産業用タンパク質分解酵素は、アルカラーゼ(Alcalase)、プロタメックス(Protamex)、ニュートラーゼ(Neutrase)、エスペーラゼ(Esperase)、フレーバーザイム(Flavourzyme)、ブロメライン(Bromelan)、Laminex Super 3G又はマキサジム(Maxazyme)(NovoNordisk Biochem)の中から選択されたタンパク質分解酵素である。
好ましくは、Bromelain 1200GDU、Laminex Super 3G、プロタメックス(Protamex)又はフレーバーザイム(Flavourzyme)の中から選択された少なくとも一つを0.2~0.4%(w/v)添加して酵素分解させた後、95~100℃で30~50/secにて加熱して酵素を失活させる。前記加水分解物の酵素反応を停止させた後、11,000~12,000×gで14~16分間遠心分離してエンドウ酵素分解物を得る。
3) Enzymatic decomposition of pea powder After homogenizing water and pea powder at a ratio of 9 to 10:1, add commercial proteolytic enzyme 0.1 to 1.0% (w/v) to pH 4 to 5. Hydrolyze in a shaking constant temperature water bath at 40-50°C for 10-30 minutes.
Industrial proteolytic enzymes include Alcalase, Protamex, Neutrase, Esperase, Flavourzyme, Bromelan, Laminex Super 3G or Maxazim. xazyme)( This is a proteolytic enzyme selected from NovoNordisk Biochem).
Preferably, enzymatic degradation is performed by adding 0.2 to 0.4% (w/v) of at least one selected from Bromelain 1200GDU, Laminex Super 3G, Protamex, or Flavourzyme. After that, the enzyme is deactivated by heating at 95 to 100°C and 30 to 50/sec. After stopping the enzymatic reaction of the hydrolyzate, it is centrifuged at 11,000-12,000×g for 14-16 minutes to obtain a pea enzymatically decomposed product.
エンドウをブランチングして急冷した後、酵素分解時の酵素濃度が高いほど、活性化時間が長いほど、硬度は低くなる現象を示すことが分かる。 It can be seen that after blanching and quenching peas, the higher the enzyme concentration during enzymatic decomposition and the longer the activation time, the lower the hardness.
4)酵素分解物の乾燥、篩別、異物除去
エンドウ酵素分解物を50~60℃で7~8時間水分含有量8~9%に乾燥させた後、0.4~0.6mm以下に篩別し、鉄又はステンレス金属、石、プラスチックなどの異物を除去する。
4) Drying, sieving, and removing foreign matter from the enzymatically decomposed product After drying the enzymatically decomposed product at 50 to 60°C for 7 to 8 hours to a moisture content of 8 to 9%, sieve to a size of 0.4 to 0.6 mm or less. Separate and remove foreign objects such as iron or stainless steel metals, stones, and plastics.
5)粥プレミックスの混合
タンパク質含有量40~60w%のエンドウ粉末10~50w%、米混合物(完全米、米グリッツ、米粉)60~99w%、米糠粉末1~40w%、分枝アミノ酸1%~10%、及び微量のビタミンとミネラルを混ぜて粥プレミックスを作る。
前記分枝アミノ酸は、ロイシン、イソロイシン、バリンが1:0.5:0.5の割合で混合されて1%~10%を含むことができる。
前記ビタミンは、ビタミンA、B、C、D、E及びKなどを含むことができ、好ましくは、ビタミンA、B、Cの少なくとも一つを含むことができる。前記ビタミンは、粥プレミックス100重量部に対してビタミンA70~80μgRAE/100g、ビタミンC8~12mg/100g、ビタミンB2(リボフラビン)0.14~0.16mg/100gを含むことができる。
前記ミネラルは、セレン、亜鉛(又は酸化亜鉛)、マグネシウム、銅などを含むことができるが、これらに限定されない。好ましくは、カルシウム、亜鉛及びマグネシウムのうちの少なくとも1つを含むことができる。前記ミネラルは、粥プレミックス100重量部に対して、カルシウム70~90mg/100g、亜鉛8~12mg/100g及びマグネシウム50~70mg/100gを混合して粥プレミックスを作る。ミネラルは免疫機
能と抗炎症機能に役立つ。
これらのビタミンとミネラルは、韓国食品医薬品安全処の1日の栄養要求量の10%以上を満たすことができる。
5) Mixing of porridge premix Pea powder 10-50w% with protein content 40-60w%, rice mixture (complete rice, rice grits, rice flour) 60-99w%, rice bran powder 1-40w%, branched amino acids 1% Make a porridge premix by mixing ~10% and trace amounts of vitamins and minerals.
The branched amino acids may include 1% to 10% of leucine, isoleucine, and valine mixed in a ratio of 1:0.5:0.5.
The vitamins may include vitamins A, B, C, D, E, and K, and preferably include at least one of vitamins A, B, and C. The vitamins may include 70 to 80 μg RAE/100 g of vitamin A, 8 to 12 mg/100 g of vitamin C, and 0.14 to 0.16 mg/100 g of vitamin B2 (riboflavin) per 100 parts by weight of the porridge premix.
The minerals may include, but are not limited to, selenium, zinc (or zinc oxide), magnesium, copper, and the like. Preferably, it may contain at least one of calcium, zinc and magnesium. The minerals are prepared by mixing 70 to 90 mg/100 g of calcium, 8 to 12 mg/100 g of zinc, and 50 to 70 mg/100 g of magnesium to 100 parts by weight of the premix of porridge. Minerals help with immune and anti-inflammatory functions.
These vitamins and minerals can meet more than 10% of the daily nutritional requirements set by the Korean Ministry of Food and Drug Safety.
<実施例1~4>
エンドウ1kgを常温の精製水で洗浄してエンドウと精製水を1:3の割合で3時間浸漬した後、笊で水気を除去して脱水した。
エンドウを80℃で30分間ブランチングして酵素を失活させた。さらに、ブランチングしたエンドウを0℃で1時間急速に冷却した。ブランチング及び急冷冷却したエンドウを55℃で8時間水分含有量8%に乾燥させた後、90~100メッシュに粉砕した。
水とエンドウ粉末を10:1で混合し、均質化させた後、Bromelain 1200GDU、Laminex Super 3G、プロタメックス(Protamex)又はフレーバーザイム(Flavourzyme)の中から選択された少なくとも1つを0.1~1.0%(w/v)添加してpH4~5、40~50℃で10~30分間振盪恒温水槽で加水分解させた後、95~100℃で30~50/sec加熱して酵素を失化させる。
前記加水分解物の酵素反応を停止させた後、11,000~12,000×gで14~16分間遠心分離してエンドウ酵素分解物を得る。粉砕したエンドウ粉末10~50w%を米混合物60~99w%、安定化した米糠1~40w%、分枝アミノ酸1~10%、ビタミン3種のビタミンA75μgRAE/100g以上、ビタミンC10mg/100g以上、ビタミンB2(リボフラビン)0.15mg/100g以上、及びミネラル3種のカルシウム80mg/100g以上、亜鉛10mg/100g以上、マグネシウム60mg/100g以上(混合6種)と混合して粥ミックスを製造した。
本発明の配合比には、高齢者の消化、咀嚼、栄養機能を補うためにビタミン3種及びミネラル3種を、1日栄養要求量の10%以上を満たすことができる量で含んでいる。さらに、本発明の「米混合物、米糠及びエンドウタンパク質BCAAアミノ酸が混合された高タンパク質機能性粥プレミックス(牛肉野菜粥)」に対して韓国機能食品研究院にタンパク質と分枝アミノ酸成分を分析依頼(2021年11月15日)した。粗タンパク質18.08%、ロイシン3028mg/100g、イソロイシン1494.93mg/100g、バリン1665.30mg/100gが含有されたという結果を得た。これらのタンパク質とアミノ酸は、1日栄養要求量の約30%を満たす非常に良好な栄養成分であることが分かる。本発明者が牛肉野菜粥プレミックスを水原女子大学に栄養成分分析依頼(2017年6月13日)したので、タンパク質7.8mg/100gという結果を得たことがある。これと比較すると、エンドウと分枝アミノ酸を用いた本発明は、タンパク質含有量が3.9倍以上高くなって優れた栄養素であることが分かる。
<Examples 1 to 4>
1 kg of peas were washed with purified water at room temperature, immersed in the peas and purified water at a ratio of 1:3 for 3 hours, and then dehydrated by removing moisture with a strainer.
Peas were blanched at 80°C for 30 minutes to inactivate the enzyme. Furthermore, the blanched peas were rapidly cooled at 0° C. for 1 hour. The blanched and quenched peas were dried at 55° C. for 8 hours to a moisture content of 8% and then ground to 90-100 mesh.
After mixing water and pea powder in a ratio of 10:1 and homogenizing, at least one selected from Bromelain 1200GDU, Laminex Super 3G, Protamex or Flavourzyme was added to 0.1 ~1.0% (w/v) was added and hydrolyzed at pH 4-5 at 40-50°C for 10-30 minutes in a constant-temperature shaking water bath, then heated at 95-100°C for 30-50/sec. to dissipate.
After stopping the enzymatic reaction of the hydrolyzate, it is centrifuged at 11,000-12,000×g for 14-16 minutes to obtain a pea enzymatically decomposed product. 10-50w% of crushed pea powder, 60-99w% of rice mixture, 1-40w% of stabilized rice bran, 1-10% of branched amino acids, 3 types of vitamin A: 75μg RAE/100g or more, vitamin C 10mg/100g or more, vitamin A porridge mix was produced by mixing 0.15 mg/100 g or more of B2 (riboflavin) and three minerals: calcium 80 mg/100 g or more, zinc 10 mg/100 g or more, and magnesium 60 mg/100 g or more (6 types of mixture).
The blending ratio of the present invention includes three types of vitamins and three types of minerals in an amount that can satisfy 10% or more of the daily nutritional requirement in order to supplement the digestion, mastication, and nutritional functions of elderly people. Furthermore, we requested the Korea Functional Food Research Institute to analyze the protein and branched amino acid components of the "high protein functional porridge premix (beef vegetable porridge) containing rice mixture, rice bran, and pea protein BCAA amino acids" of the present invention. (November 15, 2021). The results showed that it contained 18.08% crude protein, 3028 mg/100 g of leucine, 1494.93 mg/100 g of isoleucine, and 1665.30 mg/100 g of valine. It turns out that these proteins and amino acids are very good nutritional components that meet about 30% of the daily nutritional requirement. The present inventor requested a nutritional component analysis of the beef vegetable porridge premix to Suwon Women's University (June 13, 2017), and the result was that the protein was 7.8 mg/100 g. In comparison, the present invention, which uses peas and branched amino acids, has a protein content that is 3.9 times higher, indicating that it is an excellent nutrient.
本発明の粥プレミックスは、活動性の弱い患者に提供される食品であって、食事給与を介して健康な状態を維持させるためには免疫体系の損傷があってはならず、体重の変化があってはならない。したがって、免疫力試験(in vitro)と体重変化(in vivo)実験を行った。 The porridge premix of the present invention is a food provided to patients with low activity, and in order to maintain a healthy state through food feeding, there must be no damage to the immune system, and there must be no change in body weight. There should be no. Therefore, an immunity test (in vitro) and a weight change (in vivo) experiment were conducted.
<実験例1>免疫力試験(in vitro)
米混合物と米糠の粥プレミックス(1)と、米混合物に米糠、エンドウ、分枝アミノ酸、ビタミン及びミネラルが混合された高機能性粥プレミックス(2)を対象に、免疫体系の損傷、体重の変化、並びに白血球及びDNAの損傷の有無を実験した。
<Experiment Example 1> Immunity test (in vitro)
A porridge premix of rice mixture and rice bran (1) and a high-performance porridge premix (2) in which rice mixture is mixed with rice bran, peas, branched amino acids, vitamins and minerals were used to assess damage to the immune system and body weight. Experiments were conducted to determine changes in the number of cells, as well as the presence or absence of damage to white blood cells and DNA.
粥プレミックス(1)と本発明の高機能性粥プレミックス(2)の先天性免疫増強効果を分析するために、これらの抽出物の投与による酸化窒素(Nitric oxide)生成量と、先天性免疫に関連したサイトカインであるインターロイキンのIL-6、IL-12及びTNF-α(tumor necrosis factor-alpha)の発現量を測定した。 In order to analyze the innate immunity enhancing effects of the porridge premix (1) and the highly functional porridge premix (2) of the present invention, we investigated the amount of nitric oxide produced by administering these extracts and the innate immunity The expression levels of interleukins IL-6, IL-12, and TNF-α (tumor necrosis factor-alpha), which are immune-related cytokines, were measured.
1)Nitric oxide生成量の測定
マウスRAW264.7細胞を1×105cell/wellの濃度で48ウェルプレートに入れた後、LPSをポジティブコントロール(positive control)とし、それぞれ試料を100μg/mL処理した。24時間培養した後、細胞培養上清を得、Griess reagentを用いてNO生成量を測定した。RP(1)(米混合物+米糠)、RP(2)(米混合物+米糠+エンドウ+ビタミン+ミネラル)を投与したマウス細胞における酸化窒素(Nitric oxide)生産量測定結果は、図2に示すように、RP(1)よりもRP(2)でNO生成量が60%以上高いことが分かる。
1) Measurement of nitric oxide production amount Mouse RAW264.7 cells were placed in a 48-well plate at a concentration of 1×10 5 cells/well, and each sample was treated with 100 μg/mL of LPS as a positive control. . After culturing for 24 hours, a cell culture supernatant was obtained, and the amount of NO produced was measured using Griess reagent. The measurement results of nitric oxide production in mouse cells administered with RP (1) (rice mixture + rice bran) and RP (2) (rice mixture + rice bran + peas + vitamins + minerals) are as shown in Figure 2. It can be seen that the NO production amount is 60% higher in RP (2) than in RP (1).
2)先天性免疫関連サイトカインの測定
IL-6の発現量測定は、Mouse RAW264.7細胞を1×105cells/wellの濃度で48ウェルプレートに入れた後、LPSをポジティブコントロール(positive control)とし、試料を100μg/mL処理した。48時間培養した後、細胞培養上清を得、ELISAキットを用いてIL-6生産量を測定した。
2) Measurement of innate immunity-related cytokines To measure the expression level of IL-6, Mouse RAW264.7 cells were placed in a 48-well plate at a concentration of 1×10 5 cells/well, and then LPS was used as a positive control. The sample was treated with 100 μg/mL. After culturing for 48 hours, cell culture supernatants were obtained and the amount of IL-6 produced was measured using an ELISA kit.
IL-12の発現量は、Mouse RAW264.7細胞を1×105cells/wellの濃度で48-well cultureplatesに入れた後、LPSをポジティブコントロール(positive control)とし、試料を100μg/mL処理した。48時間培養した後、細胞培養上清を得、ELISAキットを用いてIL-12生産量を測定した。 The expression level of IL-12 was determined by placing Mouse RAW264.7 cells in 48-well culture plates at a concentration of 1×10 5 cells/well, then treating the sample with LPS at 100 μg/mL as a positive control. . After culturing for 48 hours, cell culture supernatants were obtained, and the amount of IL-12 produced was measured using an ELISA kit.
TNF-αの発現量測定は、Mouse RAW264.7細胞を1×105cells/wellの濃度で48ウェルプレートに入れた後、LPSをポジティブコントロール(positive control)とし、試料を100μg/mL処理した。48時間培養した後、細胞培養上清を得、ELISAキットを用いてTNF-α生産量を測定した。 To measure the expression level of TNF-α, Mouse RAW264.7 cells were placed in a 48-well plate at a concentration of 1×10 5 cells/well, and then LPS was used as a positive control and the sample was treated at 100 μg/mL. . After culturing for 48 hours, cell culture supernatants were obtained and the amount of TNF-α produced was measured using an ELISA kit.
RP(1)(米混合物+米糠)、RP(2)(米混合物+米糠+エンドウ+ビタミン+ミネラル)を投与したマウス細胞における先天性免疫サイトカインIL-6、IL-12、TNF-α生産量測定結果を図3に示した。本発明の粥プレミックスは、IL-6とIL-12サイトカインの発現のみが増加し、TNF-αの発現は少量増加したことを確認した。 Production of innate immune cytokines IL-6, IL-12, and TNF-α in mouse cells administered with RP (1) (rice mixture + rice bran) and RP (2) (rice mixture + rice bran + peas + vitamins + minerals) The measurement results are shown in FIG. It was confirmed that the porridge premix of the present invention only increased the expression of IL-6 and IL-12 cytokines, and slightly increased the expression of TNF-α.
3)後天性免疫関連サイトカインの測定
粥プレミックスRP(1)(米混合物+米糠)と本発明のタンパク質高機能性粥プレミックスRP(2)(米混合物+米糠+エンドウ+ビタミン+ミネラル)の後天性免疫増進効果を分析するために、これら抽出物の投与によるサイトカインであるIL-2、IFN-γ(interferon-gamma)の発現量を測定した。
3) Measurement of acquired immune-related cytokines Porridge premix RP (1) (rice mixture + rice bran) and protein highly functional porridge premix RP (2) of the present invention (rice mixture + rice bran + peas + vitamins + minerals). In order to analyze the acquired immunity enhancing effect, the expression levels of cytokines IL-2 and IFN-γ (interferon-gamma) due to administration of these extracts were measured.
IL-2の発現量測定は、Mouse脾臓細胞を2×106cells/wellの濃度で48ウェルプレートに入れた後、ConAをポジティブコントロール(positive control)とし、試料を100μg/mL処理した。48時間培養した後、細胞培養上清を得、ELISAキットを用いてIL-2生産量を測定した。 To measure the expression level of IL-2, mouse spleen cells were placed in a 48-well plate at a concentration of 2×10 6 cells/well, and then ConA was used as a positive control and the sample was treated at 100 μg/mL. After culturing for 48 hours, cell culture supernatants were obtained and the amount of IL-2 produced was measured using an ELISA kit.
IFN-γの発現量測定は、Mouse脾臓細胞を2×106cells/wellの濃度で48ウェルプレートに入れた後、ConAをポジティブコントロール(positive control)とし、試料を100μg/mL処理した。48時間培養した後、細胞培養上清を得、ELISAキットを用いてIFN-γ生産量を測定した。RP(1)(米混合物+米糠)、RP(2)(米混合物+米糠+エンドウ+ビタミン+ミネラル)を投与したマウス細胞における後天性免疫サイトカイン生産量測定結果を図4に示した。根茎複合植物抽出物を投与したマウス細胞における後天性免疫サイトカインIL-2及びIFN-γ発現量はいずれも増加することが分かる。以上の結果から、本発明の粥プレミックスは、酸化窒素生成量及び先天性免疫と後天性免疫の全てのサイトカインの発現量が増加することが分かるので、高齢患者食に適している。 To measure the expression level of IFN-γ, mouse spleen cells were placed in a 48-well plate at a concentration of 2×10 6 cells/well, and then ConA was used as a positive control and the sample was treated at 100 μg/mL. After culturing for 48 hours, cell culture supernatants were obtained and the amount of IFN-γ produced was measured using an ELISA kit. Figure 4 shows the measurement results of acquired immune cytokine production in mouse cells administered with RP (1) (rice mixture + rice bran) and RP (2) (rice mixture + rice bran + peas + vitamins + minerals). It can be seen that the expression levels of acquired immune cytokines IL-2 and IFN-γ both increase in mouse cells administered with the rhizome complex plant extract. From the above results, it can be seen that the porridge premix of the present invention increases the amount of nitric oxide production and the expression levels of all cytokines of innate immunity and acquired immunity, and is therefore suitable for use as a diet for elderly patients.
<実験例2>体重変化(in vivo)
粥プレミックス(1)と本発明のタンパク質高機能性粥プレミックス(2)を用いて、実験動物(マウス)を用いて体重の変化を試験した。
<Experiment Example 2> Weight change (in vivo)
Using the porridge premix (1) and the protein-rich porridge premix (2) of the present invention, changes in body weight were tested using experimental animals (mice).
粥プレミックスRP(1)(米混合物+米糠)と本発明のタンパク質高機能性粥プレミックスRP(2)(米混合物+米糠+エンドウ+分枝アミノ酸+ビタミン+ミネラル)で一般飼料(LabDiet、Laboratory Rodent Diet 5001)のそれぞれ20%を代替した飼料と、対照群としての一般飼料を製造した。6週齢、体重20g~25gのオスC57 BL/6マウス10匹を対象に2週間摂取させながら、上記の(1)と(2)及び対照区の1週間後、2週間後の体重の変化を測定し、2週間後のマウスを剖検して血液を採取し、血球分析器を用いて白血球数を測定し、脾臓末梢免疫細胞のDNA損傷の程度をコメットアッセイ(comet assay)を介して分析した。個体当たり1日平均飼料摂取量4.0g/dayなので、14日間摂取量は56.0gであり、全ての実験区(1)と(2)及び対照区の有意な差があった。 General feed (LabDiet, A feed in which 20% of each of the Laboratory Rodent Diet 5001) was substituted and a general feed as a control group were produced. 10 male C57 BL/6 mice, 6 weeks old and weighing 20 to 25 g, were fed the following for 2 weeks, and the changes in body weight after 1 week and 2 weeks in the above (1) and (2) and the control group. Two weeks later, the mice were dissected to collect blood, the number of white blood cells was measured using a blood cell analyzer, and the degree of DNA damage in peripheral immune cells in the spleen was analyzed using a comet assay. did. Since the average daily feed intake per individual was 4.0 g/day, the 14-day intake was 56.0 g, and there was a significant difference between all experimental groups (1) and (2) and the control group.
1)体重変化
対照区の一般飼料摂取区に比べて、20%代替した飼料を給与した(1)と(2)は、1%~3%有意な体重増加を示した。上記の結果から、本発明のタンパク質高機能性粥プレミックス(2)を給与した飼料が粥プレミックス(1)と対照群(一般飼料)を給与した群に比べて1%~3%の体重増加を示した。したがって、本発明は、実験用マウスの体重増加をもたらす優れたタンパク質高機能性粥プレミックスであることが分かる。
1) Body weight change Compared to the control group that received regular feed, animals (1) and (2) fed 20% substituted feed showed a significant weight increase of 1% to 3%. From the above results, it was found that the feed fed with the protein-rich porridge premix (2) of the present invention had a body weight of 1% to 3% compared to the group fed with the porridge premix (1) and the control group (general feed). showed an increase. Therefore, it can be seen that the present invention is an excellent protein-rich porridge premix that provides weight gain in laboratory mice.
2)白血球数
2週間の実験期間後に剖検して白血球数を測定した結果、実験区と対照区の白血球数は、正常値(1.8~10.7K/μL)の範囲にあった。従って、本発明の実験区(1)と(2)及び対照区の白血球数は、有意差がなかった。
2) White blood cell count After the 2-week experimental period, the animals were autopsied and the white blood cell counts were measured. As a result, the white blood cell counts in the experimental group and the control group were within the normal range (1.8 to 10.7 K/μL). Therefore, there was no significant difference in the white blood cell counts between experimental groups (1) and (2) of the present invention and the control group.
3)DNA損傷
DNA損傷の程度を確認するためにコメットアッセイ(comet assay)を行った結果、実験区と対照区は、生体内DNA損傷から変化がないことを確認した。
3) DNA Damage A comet assay was performed to confirm the degree of DNA damage, and as a result, it was confirmed that there was no change from in vivo DNA damage in the experimental group and the control group.
以上の実験結果から、本発明の粥プレミックスは、細胞株実験(in vitro)と動物実験(in vivo)を介して免疫力を提供しながら、体重を増加させることができる優れた粥プレミックスを提供することができることが分かる。 From the above experimental results, it can be seen that the porridge premix of the present invention can provide an excellent porridge premix that can increase body weight while providing immunity through cell line experiments (in vitro) and animal experiments (in vivo).
本発明は、米混合物、米糠、エンドウタンパク質、分枝アミノ酸、及びビタミンとミネラルが補強された高機能性タンパク質粥を提供することができる。特に、エンドウをブランチングして急冷し、粉砕した後、タンパク質分解酵素で加水分解させてタンパク質含有量を高めることにより免疫力と体重が維持されながら、高齢患者への吸収が容易であって回復が速い。特に、保養食、食事代用食、栄養食として利用可能であるので、産業上利用可能性がある。 The present invention can provide a high-performance protein porridge enriched with rice mixture, rice bran, pea protein, branched amino acids, and vitamins and minerals. In particular, peas are blanched, rapidly cooled, crushed, and then hydrolyzed with proteolytic enzymes to increase the protein content, which maintains immunity and weight while making it easier for elderly patients to absorb and recover. is fast. In particular, it can be used as a health food, a meal substitute, and a nutritional food, so it has potential for industrial use.
Claims (5)
エンドウ粉末に水を加えて均質化させた後、商業用タンパク分解酵素を用いて加水分解させるステップと、
前記加水分解させた物を熱処理して酵素を失活させた後、遠心分離してエンドウ酵素分解物を得るステップと、
前記エンドウ酵素分解物を乾燥させた後、篩別して異物を除去するステップと、
エンドウ粉末、米混合物(完全米、米グリッツ、米粉末)、米糠粉末、分枝アミノ酸、及び微量のビタミンとミネラルを混合して粥プレミックスを作るステップと、
を含んでなる、タンパク質高機能性粥プレミックスの製造方法。 washing the peas with water, soaking them, removing moisture, sterilizing and blanching the peas at a high temperature, and rapidly cooling the peas at a low temperature; pulverizing the peas;
homogenizing the pea powder with water and then hydrolyzing it using a commercial proteolytic enzyme;
a step of heat-treating the hydrolyzed product to inactivate the enzyme, and then centrifuging it to obtain a pea enzymatically decomposed product;
After drying the pea enzymatically decomposed product, sieving it to remove foreign substances;
mixing pea powder, rice mixture (complete rice, rice grits, rice powder), rice bran powder, branched amino acids, and trace amounts of vitamins and minerals to form a porridge premix;
A method for producing a highly functional protein porridge premix comprising.
5:0.5の割合で混合された前記分枝アミノ酸1%~10%を含有し、前記ビタミンとしてビタミンA70~80μgRAE/100g、ビタミンC8~12mg/100g、ビタミンB(リボフラビン)0.14~0.16mg/100gを含み、前記ミネラルとしてはカルシウム70~90mg/100g、亜鉛8~12mg/100g、マグネシウム50~70mg/100gを含んで混合することにより、前記粥プレミックスを作ることを特徴とする、請求項1に記載のタンパク質高機能性粥プレミックスの製造方法。 In the porridge premix consisting of 60-99 w% of the rice mixture (complete rice, rice grits, rice powder) and 1-40 w% of the rice bran powder, 10-50 w% of the pea powder with a protein content of 40-60 w%. , and leucine, isoleucine, and valine at 1.0:0.
Contains 1% to 10% of the branched amino acids mixed at a ratio of 5:0.5, and the vitamins include vitamin A 70 to 80 μg RAE/100g, vitamin C 8 to 12 mg/100g, and vitamin B (riboflavin) 0.14 to 0.16 mg/100 g, and the minerals include 70 to 90 mg/100 g of calcium, 8 to 12 mg/100 g of zinc, and 50 to 70 mg/100 g of magnesium to make the porridge premix. The method for producing the protein highly functional porridge premix according to claim 1 .
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2021-0174435 | 2021-12-08 | ||
KR1020210174435A KR20230086836A (en) | 2021-12-08 | 2021-12-08 | A high protein functional porridge premix containing the rice mixture and stabilized rice bran and pea and the method of manufacturing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023085194A JP2023085194A (en) | 2023-06-20 |
JP7454281B2 true JP7454281B2 (en) | 2024-03-22 |
Family
ID=86635414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022141906A Active JP7454281B2 (en) | 2021-12-08 | 2022-09-07 | Highly functional protein porridge premix containing peas, rice mixture, and rice bran and method for producing the same |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP7454281B2 (en) |
KR (1) | KR20230086836A (en) |
CN (1) | CN116235923A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014519842A (en) | 2011-06-23 | 2014-08-21 | インノヴァフード アクチエボラグ | Improved food composition |
KR101441565B1 (en) | 2013-05-24 | 2014-09-22 | (주)푸른가족 | A functional porridge premix containing the rice mixture and stabilized rice bran and the method of manufacturing the same |
JP2017529086A (en) | 2014-09-01 | 2017-10-05 | マゼ ジョリー ヴァダケムリ | Optimal nutrition food |
CN108065414A (en) | 2016-11-15 | 2018-05-25 | 内蒙古伊利实业集团股份有限公司 | A kind of edible composition and its application with strengthen immunity |
JP2019142976A (en) | 2019-06-04 | 2019-08-29 | 株式会社東洋新薬 | Adjuvant |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10806169B2 (en) | 2018-05-15 | 2020-10-20 | Kate Farms, Inc. | Hydrolyzed pea protein-based nutrient composition |
US20190374569A1 (en) | 2018-06-12 | 2019-12-12 | Richard Laver | Intact pea protein-based nutrient composition |
KR102028652B1 (en) | 2018-08-03 | 2019-10-04 | 주식회사 휴바이오센트릭 | Powder type multiple food supplement comprising pisum sativum powder, fermented rice bran, embryo bud of rice, angelica gigas extract powder, ginseng extract powder, honey powder and cocoa powder |
-
2021
- 2021-12-08 KR KR1020210174435A patent/KR20230086836A/en not_active Application Discontinuation
-
2022
- 2022-09-07 JP JP2022141906A patent/JP7454281B2/en active Active
- 2022-10-20 CN CN202211287644.4A patent/CN116235923A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014519842A (en) | 2011-06-23 | 2014-08-21 | インノヴァフード アクチエボラグ | Improved food composition |
KR101441565B1 (en) | 2013-05-24 | 2014-09-22 | (주)푸른가족 | A functional porridge premix containing the rice mixture and stabilized rice bran and the method of manufacturing the same |
JP2017529086A (en) | 2014-09-01 | 2017-10-05 | マゼ ジョリー ヴァダケムリ | Optimal nutrition food |
CN108065414A (en) | 2016-11-15 | 2018-05-25 | 内蒙古伊利实业集团股份有限公司 | A kind of edible composition and its application with strengthen immunity |
JP2019142976A (en) | 2019-06-04 | 2019-08-29 | 株式会社東洋新薬 | Adjuvant |
Also Published As
Publication number | Publication date |
---|---|
JP2023085194A (en) | 2023-06-20 |
KR20230086836A (en) | 2023-06-16 |
CN116235923A (en) | 2023-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Qin et al. | A review on plant-based proteins from soybean: Health benefits and soy product development | |
KR100734721B1 (en) | Vasodilator pharmaceutical preparation and health food composition | |
KR101542667B1 (en) | Manufacturing method of fermented food using rice bran and embryo and linseed | |
CN108185288A (en) | A kind of full nutrition stomach invigorating generation meal rice is dilute and preparation method thereof and application method and purposes | |
KR102143027B1 (en) | Non-diary formulae | |
KR102060283B1 (en) | Method for producing of natural powdered food comprising Tenebrio molitor powder with increased palatability | |
JPS585020B2 (en) | Nutritionally enriched food containing stupon fine powder as the main ingredient | |
CN107927512A (en) | A kind of oligopeptide weight losing meal-replacing solid beverage | |
Abedini et al. | Oilseed cakes in the food industry; a review on applications, challenges, and future perspectives | |
JP7454281B2 (en) | Highly functional protein porridge premix containing peas, rice mixture, and rice bran and method for producing the same | |
CN105795149A (en) | Piglet milk powder with high nutrition and high absorbability and preparation method thereof | |
KR101834638B1 (en) | The method of functional korea traditional cracker using the jujube | |
CN102960603B (en) | Nutrient protein powder with high digestive absorption function | |
KR101857065B1 (en) | The mineral-rich fermentation enzyme sunsik and a method of manufacturing | |
KR102276314B1 (en) | Method for Preparing Functional Mixed Concentrate Protein Extract and Plant based Meat Alternatives and Use thereof | |
KR20180071047A (en) | Composition of baby food and nourishing food for pet | |
KR20120098063A (en) | Health functional snack containing grasshoppers and manufacturing method of thereof | |
KR100376596B1 (en) | Sauce capable of eliminating cholesterol using various seeds material | |
Gbaa et al. | Effect of watermelon rind (Citrullus lanatus) addition on the chemical and sensory quality of sorghum based mumu | |
KR20050045666A (en) | Composition for inhibiting of obesity | |
RU2612796C1 (en) | Functional purpose nutritional mixture | |
CN110214893A (en) | Full nutritious food of linseed bean powder and preparation method thereof | |
KR102300137B1 (en) | Low-carbohydrate diet bar and manufacturing method thereof | |
KR20200086761A (en) | Energy bars made in sweet jelly of red beans that include Amino and manufacturing method thereof | |
CN102499375A (en) | Preparation method for health-care food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220907 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231024 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231124 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240206 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240304 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7454281 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |